jcb24894.pdf (71.36 kB)
Why regenerative stem cell medicine progresses slower than expected
journal contribution
posted on 2023-06-08, 18:42 authored by Achim RosemannStem cell research has been acclaimed to revolutionize the future of medicine, and to offer new treatments for previously incurable diseases. Despite years of research, however, the therapeutic potential of stem cell research has not yet been fully realized. By June 2014, the US Food and Drug Administration had approved only five stem cell-based medicinal products, all of which cord blood derived hematopoietic stem cell products for the cure of blood and immunological diseases. Anticipated treatments for cancer, neurodegenerative disorders, gastroenterological, myocardial, and other diseases are still far from routine applications. What are the reasons for the slow progress in the stem cell field, and the mismatch between public expectations and actual achievements?
Funding
Bionetworking in Asia - International collaboration, exchange, and responsible innovation in the life sciences; G0750; ESRC-ECONOMIC & SOCIAL RESEARCH COUNCIL; ES/I018107/1
History
Publication status
- Published
File Version
- Published version
Journal
Journal of Cellular BiochemistryISSN
0730-2312Publisher
John Wiley & SonsExternal DOI
Issue
12Volume
115Page range
2073-2076Department affiliated with
- Anthropology Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2014-10-16First Open Access (FOA) Date
2014-10-28First Compliant Deposit (FCD) Date
2014-10-15Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC